Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
L.Carmo-RodriguesM
For a lot of people, a moderate low-carb approach is the most sustainable place to start, because there is no calorie counting and less of the hunger that makes diets hard to stick with
After propensity score matching against multiple antidiabetic drug classes (insulin, metformin, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas), results showed: No significant increase in thyroid cancer incidence Median follow-up of ~4.5 years Risk estimates comparable or lower than other glucose-lowering therapies Overall, current epidemiological evidence does not support a clinically meaningful increase in thyroid cancer risk in humans
doi:10.1016/j.phrs.2016.02.020
US$ 21.72
US$ 28.85
US$ 29.86
US$ 23.56
US$ 28.91
US$ 21.56
US$ 20.57
US$ 27.85
US$ 21.02
US$ 24.96
